India: The high cost of filing a patent on a gene sequences from spicyipindia.blogspot.com Biotechnology is an extremely fast-moving field in which new products and services are developed from an increasingly complex and cumulative set of underlying technologies. Latest treatments to diseases come from biotechnology where sequencing genes, identifying ... Share via E–mail | Twitter | Facebook
A "Fair" Education in a Copyright World? from spicyipindia.blogspot.com Mainstream media in India has been abuzz with news of a copyright raid conducted against a small photocopy shop by leading publishers. The allegedly infringing material are course packs containing extracts from different books that ... Share via E–mail | Twitter | Facebook
Are there too many patents? from ipfinance.blogspot.com After too long an interval, the IP Finance weblog is delighted to welcome back one of our star guest bloggers, Keith Mallinson (
WiseHarbor), who has in the past provided some sharp and pertinent insights into ...
Share via E–mail | Twitter | Facebook
BPAI indefinite inconsistency panels at least one panel from allthingspros.blogspot.com BPAI affirms indefiniteness when claim positively recites "at least one flooring panel" and then refers to "panels of the least one flooring panel"
Takeaway: During prosecution, the Examiner rejected a claim to a flooring system ...
Share via E–mail | Twitter | Facebook
Guest Post: Securitization of IP - Part A from spicyipindia.blogspot.com SpicyIP brings you a 2 part guest post series on a topic we have spoken very little about on the blog - Securitization of Intellectual Property. Nehaa Chaudhari, a 5th year student at Nalsar University of ...
Share via E–mail | Twitter | Facebook
Disjointed Patent Claims and the Search for Prior Art from www.ipwatchdog.com U.S. Patent No. 6,757,068, which relates to what is described as a sourceless tracking system. See AOP Patent Study DEV-1754. The claims of this patent are extremely broad and suffer from defects ...
Share via E–mail | Twitter | Facebook
Debunking Innovative Copycats and the Patent Monopoly from www.ipwatchdog.com The moral of the story for those in the anti-patent community is this: get a clue! Why not do something radical like becoming informed on the topics on which you pontificate? Treating patents like they ...
Share via E–mail | Twitter | Facebook
Court Considers “Broader Public Interest” Where Injunction Against Patent Infringement is Sought from www.iposgoode.ca Recently, the Supreme Court of Appeal of South Africa, the highest court in South Africa, considered “public-interest” factors used in other jursidictions to grant an injunction against alleged patent infringement on grounds of prejudice to ...
Share via E–mail | Twitter | Facebook
Solvay v. Honeywell and an Alternative Route to a Central Patent Court in Europe from www.patentlyo.com Guest post by Professor Marketa Trimble (UNLV) When in 2006 the Court of Justice of the European Communities ("ECJ") clarified the rules of jurisdiction in the European Union ("EU") as they pertained to patent litigation ...
Share via E–mail | Twitter | Facebook
Apple won't demand billion-dollar payment or bond from Samsung for at least a few months from www.fosspatents.com While fighting a high-stakes battle against each other, Apple and Samsung can still agree on efficient procedures on mundane issues that are merely about money and have no bearig on what they are primarily interested ...
Share via E–mail | Twitter | Facebook
Conference & CLE Calendar from www.patentdocs.org September 5, 2012 - Inter Partes Review: Rules and Strategy (Intellectual Property Owners Association ) - 2:00 - 3:00 pm September 6, 2012 - A Review of the Impact of Recent Supreme Court and Federal Circuit Decisions on ...
Share via E–mail | Twitter | Facebook
Court Report from www.patentdocs.org By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. GlaxoSmithKline LLC v. Apotex Inc. 1:12-cv-01090; filed August 31, 2012 Infringement of U.S. Patent ...
Share via E–mail | Twitter | Facebook